126 related articles for article (PubMed ID: 37493532)
1. A synergistic analgesic effect of morphine in combination with the CB1 receptor agonist, ACPA, in normal, hypothyroid, and hyperthyroid male rats.
Zarrindast MR; Khakpai F
Acta Neurobiol Exp (Wars); 2023; 83(2):154-170. PubMed ID: 37493532
[TBL] [Abstract][Full Text] [Related]
2. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB
Chen X; Cowan A; Inan S; Geller EB; Meissler JJ; Rawls SM; Tallarida RJ; Tallarida CS; Watson MN; Adler MW; Eisenstein TK
Br J Pharmacol; 2019 Sep; 176(17):3378-3389. PubMed ID: 31218677
[TBL] [Abstract][Full Text] [Related]
3. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
[TBL] [Abstract][Full Text] [Related]
5. The involvement of ventral hippocampal microglial cells, but not cannabinoid CB1 receptors, in morphine-induced analgesia in rats.
Javid H; Rezayof A; Ghasemzadeh Z; Sardari M
Acta Neurol Belg; 2020 Oct; 120(5):1077-1084. PubMed ID: 31006075
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
8. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
9. Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.
Auh QS; Chun YH; Melemedjian OK; Zhang Y; Ro JY
Brain Res Bull; 2016 Jul; 125():211-7. PubMed ID: 27450703
[TBL] [Abstract][Full Text] [Related]
10. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS
Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490
[TBL] [Abstract][Full Text] [Related]
11. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
12. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
[TBL] [Abstract][Full Text] [Related]
13. Synergistic analgesic effect of morphine and tramadol in non‑sensitized and morphine‑sensitized mice: an isobolographic study.
Khakpai F; Nedaei F; Shahini F; Zarrindast MR
Acta Neurobiol Exp (Wars); 2021; 81(4):350-361. PubMed ID: 35014984
[TBL] [Abstract][Full Text] [Related]
14. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
15. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid CB
Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference.
Rezayof A; Sardari M; Zarrindast MR; Nayer-Nouri T
Behav Brain Res; 2011 Jun; 220(1):1-8. PubMed ID: 21262265
[TBL] [Abstract][Full Text] [Related]
18. CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens.
Molaei M; Fatahi Z; Zaringhalam J; Haghparast A
J Mol Neurosci; 2016 Apr; 58(4):446-55. PubMed ID: 26803309
[TBL] [Abstract][Full Text] [Related]
19. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice.
Yu Y; Tsang QK; Jaramillo-Polanco J; Lomax AE; Vanner SJ; Reed DE
J Neurosci; 2022 Aug; 42(33):6313-6324. PubMed ID: 35790401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
